Governing Statute & License Authority
Health & Safety Code § 11835 — DHCS Opioid Treatment Program (OTP) / Narcotic Treatment Program (NTP) License (California Department of Health Care Services)
Administered by the California Department of Health Care Services (DHCS), Substance Use Disorder (SUD) Compliance Division. Primary license verification: DHCS SUD Certified Provider Directory at dhcs.ca.gov. Health & Safety Code § 11835 (California Narcotic Treatment Program law) requires an active DHCS license for any program that dispenses methadone (methadone hydrochloride) or other opioid agonist medications — including buprenorphine dispensed by a facility rather than prescribed by an individual DEA-waivered practitioner — for the treatment of opioid use disorder (OUD). Opioid Treatment Programs (OTPs) or Narcotic Treatment Programs (NTPs) provide: (1) opioid agonist medication-assisted treatment (OAT/MAT): dispensing methadone, buprenorphine, or naltrexone to patients with opioid use disorder as the primary pharmacological component of treatment — the Schedule II controlled substance status of methadone and the DEA regulatory framework for OTPs create a distinct licensing regime separate from general SUD outpatient treatment; (2) counseling services: OTPs must provide addiction counseling, either individually or in group formats, as a required component of the treatment program — DHCS § 11835 requires that counseling services be integrated with medication dispensing, not provided merely as a nominal add-on; (3) medical oversight: OTPs must be under the direction of a physician who assumes responsibility for the treatment of each patient enrolled in the OTP, including initial medical assessment, treatment dose determination, and ongoing medical review; (4) federal DEA registration: in addition to the DHCS § 11835 license, OTPs dispensing methadone must hold a DEA Schedule II narcotic treatment program registration (DEA Form 363) — the DHCS license and DEA registration are separate but related requirements; (5) CSAT federal certification: OTPs must also be certified by SAMHSA's Center for Substance Abuse Treatment (CSAT) under 42 CFR Part 8. The combination of DHCS license, DEA registration, and CSAT certification creates a three-way licensing requirement for lawful OTP operation in California.
Section 11835 establishes that operating a methadone dispensing program without an active DHCS OTP license is unlawful and generates the most serious regulatory and criminal exposure of any SUD licensing violation. The unlicensed OTP pattern includes: (a) operators running methadone dispensing programs without ever obtaining a DHCS § 11835 license, a DEA Schedule II narcotic treatment program registration, or CSAT federal certification — operating with none of the required authorizations; (b) operators whose DHCS OTP license has expired but who continue dispensing methadone to existing patients — a lapsed DHCS license makes all continued methadone dispensing unlawful, regardless of the patients' physical dependence on continued dosing; (c) office-based opioid treatment (OBOT) practitioners prescribing buprenorphine to individual patients under DATA 2000 waivers (now eliminated under the SUPPORT Act) who transition to facility-based dispensing operations without obtaining DHCS OTP licensure and DEA OTP registration; (d) "suboxone clinics" that dispense buprenorphine to groups of patients as an OTP facility dispensing program without the required DHCS OTP license or DEA OTP registration. Harm from unlicensed OTP operation is acute: methadone has a narrow therapeutic window and significant overdose risk, particularly when dispensed without physician-directed dosing protocols, take-home criteria, and diversion prevention — unlicensed OTPs that dispense methadone without these protocols create direct risk of patient and community overdose deaths.
THE ONLY California DHCS Licensed OTP § 11835 Page in This Series
This is THE ONLY California DHCS Licensed Opioid Treatment Program (OTP / Narcotic Treatment Program) Health & Safety Code § 11835 fee-petition-mechanics page in the ClaimHour fee-petition-mechanics series.
DISTINCT FROM: DHCS Licensed Substance Use Disorder Outpatient Program § 11834.11 (SUD Outpatient provides non-OTP outpatient counseling and behavioral health services for SUD without methadone dispensing; SUD Outpatient programs may not dispense methadone or operate as an OTP; a SUD Outpatient program operator who begins dispensing methadone to patients without a DHCS OTP license violates both § 11834.11 and § 11835) / DHCS Licensed Substance Use Disorder Residential Treatment Program § 11834.01 (SUD Residential provides 24-hour therapeutic community residential treatment for SUD without methadone dispensing; residential detoxification programs that administer buprenorphine as a short-term detoxification medication under physician orders are distinct from OTP programs providing opioid agonist maintenance treatment — the key distinction is maintenance vs. detoxification and program vs. individual practitioner prescribing) / CDPH Licensed Chemical Dependency Recovery Hospital (CDRH) § 1250.3 (CDRH provides 24-hour inpatient medically supervised detoxification in a licensed hospital setting; OTP provides outpatient maintenance treatment — CDRH and OTP serve different phases of OUD treatment and have distinct licensing requirements) / DFPI or CDI Licensed Financial Entities (entirely unrelated licensing regimes — OTP is DHCS-regulated healthcare, not financial services)
Private Professional Standards Advisories PURE KETCHUM
THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH AN AATOD STANDARDS FOR OPIOID TREATMENT PROGRAMS ADVISORY
AATOD Standards for Opioid Treatment Programs (2023 Edition)
American Association for the Treatment of Opioid Dependence (AATOD) — founded 1984, New York, New York — the national trade association for opioid treatment program provider organizations, with over 600 member OTP programs collectively serving more than 350,000 patients with opioid use disorder annually through methadone and buprenorphine maintenance treatment. AATOD members operate OTPs in all 50 states and the District of Columbia, providing daily-witnessed methadone dosing, opioid agonist therapy, addiction counseling, case management, and recovery support services. AATOD's Standards for Opioid Treatment Programs establish the national OTP provider organization baseline for licensed opioid treatment program operations, clinical protocols, patient safety, and regulatory compliance. AATOD is DISTINCT from NAADAC: AATOD represents OTP provider organizations — facilities that dispense methadone or buprenorphine to patients as an organizational clinical program; NAADAC represents individual addiction counselors and addiction professionals employed within those organizations and across all addiction treatment settings — the two together establish the full OTP clinical and professional accountability framework from the program and the counselor perspectives, respectively.
AATOD Standard 1 — Active DHCS OTP License and DEA Schedule II Narcotic Treatment Registration as Prerequisite for All Opioid Agonist Maintenance Treatment: AATOD Standard 1 establishes that all AATOD member programs dispensing methadone or operating as opioid treatment programs must maintain, at all times: (a) an active DHCS § 11835 OTP license from the California Department of Health Care Services — any AATOD member program whose DHCS OTP license expires must immediately cease all methadone dispensing, notify all enrolled patients of the license lapse, and arrange for all patients' care transfer to a licensed OTP; (b) an active DEA Schedule II narcotic treatment program registration (DEA Form 363) — loss of DEA registration concurrent with or independent of DHCS license lapse makes all methadone dispensing federally prohibited under the Controlled Substances Act; (c) active SAMHSA/CSAT federal OTP certification under 42 CFR Part 8 — CSAT certification is a third required authorization layer, and AATOD Standard 1 requires that all three authorizations (DHCS license + DEA registration + CSAT certification) remain active and current; (d) license posting and patient disclosure: AATOD Standard 1 requires that the DHCS OTP license, DEA registration number, and CSAT certification be posted conspicuously in the OTP dosing area and disclosed to all enrolled patients and referring providers; (e) proactive renewal management: AATOD Standard 1 requires OTP-level organizational systems for tracking all three licensing/certification renewal deadlines with 90-day advance notice to ensure no lapse in any of the three required authorizations.
AATOD Standard 4 — Dosing Protocols, Physician Involvement, and Medical Record Requirements for Each OTP Patient: AATOD Standard 4 establishes the clinical standards for medication management and physician oversight in OTP programs: (a) initial medical assessment: each patient enrolled in an AATOD member OTP must receive a physician-conducted initial medical assessment prior to the first dose of methadone — the assessment must document the diagnosis of opioid use disorder using DSM-5 criteria, the patient's opioid use history, medical history, current medications, pregnancy status, and clinical basis for the methadone starting dose; (b) individualized dosing protocol: AATOD Standard 4 requires a written individualized dosing protocol for each patient, specifying the starting dose, dose escalation schedule, maximum dose, and criteria for dose reduction or take-home privileges — dosing decisions must be physician-directed and documented in the patient medical record; (c) physician supervision of dosing: Standard 4 requires that dose changes be authorized by a physician in writing before the change is implemented by dispensing staff — no dispensing nurse or medication aide may independently adjust methadone doses without physician authorization; (d) medical record completeness: AATOD Standard 4 requires that each patient's medical record contain the initial medical assessment, all physician orders, dispensing records (date, dose dispensed, staff name, patient signature), urine drug screen results with clinical interpretation, and counseling attendance records; (e) pregnancy protocol: AATOD Standard 4 requires specific enhanced protocols for pregnant patients — including more frequent physician assessments, obstetric coordination, dose adjustment during pregnancy, and neonatal abstinence syndrome (NAS) planning for newborns.
AATOD Standard 7 — Diversion Prevention Protocols, Take-Home Dosing Criteria, and Urine Drug Screening Documentation: Requires AATOD member OTPs to: (a) federal take-home criteria: AATOD Standard 7 requires that take-home methadone doses be provided only in strict compliance with the DEA/CSAT take-home criteria at 42 CFR § 8.12(i) — patients must meet minimum enrollment duration, stability, and attendance criteria before receiving even one take-home dose; the unlicensed OTP that provides take-home methadone without documented federal criteria compliance creates diversion risk; (b) take-home dispensing documentation: Standard 7 requires that all take-home methadone dispensing be documented with the amount dispensed, container security, patient acknowledgment of diversion prevention responsibilities, and scheduled return date; (c) urine drug screening (UDS): AATOD Standard 7 requires random urine drug screening for all enrolled patients at minimum monthly frequency, with more frequent screening for patients who have recently used illicit substances — UDS results must be documented in the patient medical record with clinical interpretation; (d) diversion incident response: Standard 7 requires that any suspected diversion of methadone — patient report of lost or stolen take-home doses, positive UDS for methadone in non-patients, community diversion incident — be documented as an incident, reviewed by the medical director, and reported to DHCS and DEA as required; (e) lockbox requirements: AATOD Standard 7 requires that all OTPs provide tamper-resistant, lockable containers for take-home methadone and document that each patient received a lockbox and understands child safety storage requirements.
These are national opioid treatment program provider association standards — PURE KETCHUM advisory evidence under Ketchum v. Moses, 24 Cal.4th 1122 (2001) — not independent fee-shifting statutes.
THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH A NAADAC CODE OF ETHICS FOR ADDICTION PROFESSIONALS ADVISORY
NAADAC Code of Ethics for Addiction Professionals (2021 Edition)
NAADAC, the Association for Addiction Professionals — formerly the National Association of Alcoholism and Drug Abuse Counselors (NAADAC, founded 1974, Alexandria, Virginia) — the national membership organization for addiction counselors, substance use disorder specialists, and other addiction professionals, with over 100,000 members including licensed addiction counselors, certified alcohol and drug counselors (CADCs), licensed clinical social workers in addiction treatment, licensed counselors (LPCCs), and addiction psychiatrists. NAADAC's Code of Ethics for Addiction Professionals establishes the national addiction professional workforce ethics baseline across all treatment settings, including DHCS-licensed OTPs. NAADAC is DISTINCT from AATOD: AATOD represents OTP provider organizations — the facilities and programs that employ addiction counselors and dispense methadone; NAADAC represents the individual addiction professionals — counselors, caseworkers, and treatment specialists — employed within those programs and across all addiction treatment settings; AATOD's standards govern organizational OTP program compliance while NAADAC's Code of Ethics governs individual addiction professional ethical conduct within those programs.
NAADAC Principle 1 — Active DHCS OTP License as Prerequisite for Addiction Counseling Practice Within an OTP Setting: NAADAC Principle 1 establishes that addiction professionals providing counseling services within an OTP setting must confirm that the OTP holds an active DHCS § 11835 license, DEA Schedule II narcotic treatment program registration, and CSAT certification as a prerequisite for providing counseling services at that program. NAADAC Principle 1 requirements include: (a) licensed setting verification: addiction professionals must verify that the OTP in which they practice holds all required state and federal licenses and certifications — an addiction counselor who knowingly provides counseling services in an unlicensed OTP participates in the unlicensed practice and may face professional license consequences; (b) counselor licensure: Principle 1 requires that addiction counselors providing individual or group therapy in California OTPs hold the applicable California license or certification — CADC (Certified Alcohol and Drug Counselor), LCSW, MFT, LPCC, or licensed psychologist — and that their scope of practice is consistent with the services they provide; (c) supervision disclosure: NAADAC Principle 1 requires that addiction counselors who are in the process of accumulating supervised hours toward full licensure disclose their status to the OTP employer and ensure that clinical supervision is provided by a qualified California-licensed supervisor; (d) conflict of interest prohibition: Principle 1 prohibits addiction counselors from receiving payments, kickbacks, or benefits from referring physicians, pharmacies, or other providers for patient referrals to the OTP — the unlicensed OTP that compensates counselors for patient solicitation violates both NAADAC Principle 1 and federal anti-kickback statutes.
NAADAC Principle 4 — Counselor Competency in OUD Treatment and 42 CFR Part 2 Patient Confidentiality: NAADAC Principle 4 establishes that addiction professionals working in OTP settings must: (a) OUD clinical competency: addiction counselors in OTPs must maintain current knowledge of opioid use disorder treatment, including the pharmacology of methadone and buprenorphine, the evidence base for opioid agonist therapy, co-occurring disorders (particularly opioid use disorder and co-occurring mental health conditions), and trauma-informed approaches to OUD counseling; NAADAC Principle 4 requires ongoing continuing education in OUD treatment for OTP counselors; (b) 42 CFR Part 2 confidentiality: all records of patients in DHCS-licensed OTPs are protected by 42 CFR Part 2 (Confidentiality of Substance Use Disorder Patient Records) — a federal regulation that provides stronger confidentiality protections than HIPAA for SUD treatment records; NAADAC Principle 4 requires that OTP addiction professionals receive training in 42 CFR Part 2 requirements, including the prohibition on disclosing patient identity, diagnosis, prognosis, or treatment to unauthorized third parties without a specific 42 CFR Part 2-compliant patient consent; (c) mandatory 42 CFR Part 2 training: Principle 4 requires that all new OTP counseling staff receive 42 CFR Part 2 training within 30 days of employment and that all staff receive annual 42 CFR Part 2 refresher training; (d) records security: NAADAC Principle 4 requires that all OTP patient records — whether paper or electronic — be maintained in secure, access-controlled systems that prevent unauthorized disclosure of protected SUD treatment information.
NAADAC Principle 7 — Mandatory Reporting and Patient Welfare Obligations in OTP Settings: Requires NAADAC-member OTP addiction professionals to: (a) patient welfare as paramount obligation: NAADAC Principle 7 establishes that OTP addiction counselors must prioritize patient welfare above program financial interests — including the obligation to report to DHCS any OTP practice that places patients at risk, including dosing irregularities, diversion facilitation, inadequate physician oversight, or patient safety hazards; (b) mandatory reporting of child abuse: OTP addiction counselors are California mandatory reporters under Penal Code § 11165.7 — Principle 7 requires immediate reporting to CDSS CCLD and law enforcement of any known or reasonably suspected child abuse or neglect involving OTP patients' children; (c) impaired colleague reporting: NAADAC Principle 7 establishes that OTP addiction professionals who observe a colleague impaired by substances at work have a professional obligation to report the colleague to the facility medical director and to their licensing board — an impaired colleague providing counseling or administering methadone in an unlicensed OTP compound ethical obligations; (d) diversion reporting obligation: Principle 7 requires OTP counselors who observe or have reason to believe that methadone or buprenorphine is being diverted — by patients, staff, or the program operator — to report the diversion to the OTP medical director and, if the medical director does not act, to DHCS and DEA; (e) license non-compliance reporting: NAADAC Principle 7 requires that addiction counselors who become aware that the OTP in which they work has lost or failed to obtain the required DHCS license, DEA registration, or CSAT certification immediately notify the OTP director and, if remediation does not occur, contact DHCS to report the unlicensed operation.
These are national addiction professional ethics and practice standards — PURE KETCHUM advisory evidence — not independent fee-shifting statutes.
TWO PRIVATE STANDARDS ON ONE PAGE: AATOD Standards for Opioid Treatment Programs (2023 Edition) + NAADAC Code of Ethics for Addiction Professionals (2021 Edition) — both PURE KETCHUM, both first-in-series.
CCP § 1021.5 Fee-Shifting Framework
California Code of Civil Procedure § 1021.5 authorizes attorney fee awards when: (1) the action results in enforcement of an important right affecting the public interest; (2) a significant benefit is conferred on the general public; and (3) the necessity and financial burden of private enforcement justify fee-shifting. Unlicensed OTP enforcement satisfies all three prongs: patients with opioid use disorder who receive methadone maintenance treatment are physically dependent on daily dosing — they cannot safely discontinue treatment without medical supervision, and they depend on the OTP to dispense controlled substances safely, prevent diversion, and provide the physician oversight and counseling that define lawful OTP treatment. Unlicensed OTPs that dispense methadone without DHCS oversight, physician direction, diversion prevention protocols, and the three-way licensing framework expose patients to dosing errors, diversion of their medication, and the absence of any regulatory mechanism to detect or prevent harm. Protection of patients with opioid use disorder from unlicensed methadone dispensing programs is a significant public benefit justifying CCP § 1021.5 fee-shifting.
Ketchum Lodestar Calculation
Under Ketchum v. Moses, 24 Cal.4th 1122 (2001), the lodestar is calculated as reasonable hours × reasonable hourly rate. PLCM Group Inc. v. Drexler, 22 Cal.4th 1084 (2000), establishes the prevailing market rate. Hensley v. Eckerhart, 461 U.S. 424 (1983), requires hours documentation. Missouri v. Jenkins, 491 U.S. 274 (1989), authorizes fees-on-fees.
AATOD + NAADAC Standards as PURE KETCHUM Lodestar Evidence
Both AATOD Standards and NAADAC Code of Ethics are private professional association standards — they do not create independent statutory fee-shifting. Their role under Ketchum is as advisory evidence establishing: (a) the OTP provider organization compliance baseline (AATOD Standards 1/4/7) and the addiction counselor workforce ethics baseline (NAADAC Principles 1/4/7) that DHCS-licensed OTP operators must maintain; (b) the specific violations committed by the unlicensed operator; and (c) the public benefit of enforcement protecting OUD patients from unlicensed methadone dispensing programs. This is the PURE KETCHUM posture: OTP provider organization standards (AATOD) and addiction professional ethics standards (NAADAC) as lodestar evidence from two distinct accountability dimensions — not independent fee triggers.
DHCS OTP License Verification — Welch Anchor
Under Welch v. Metropolitan Life Ins. Co., 480 F.3d 942 (9th Cir. 2007), fee petitions require a Welch declaration establishing prevailing market rate. In § 11835 unlicensed OTP matters, the primary Welch anchor is the DHCS SUD Certified Provider Directory at dhcs.ca.gov — confirming no active DHCS § 11835 OTP license for the program address. DEA registrant verification at the DEA Diversion Control Division confirms no active narcotic treatment program registration. Patient dispensing records, physician oversight documentation (or absence), urine drug screening records, take-home criteria documentation (or absence), and diversion incident records establish the specific harm elements for each unlicensed OTP matter.
Frequently Asked Questions
- What three separate authorizations does a California OTP need to legally dispense methadone?
- A California OTP dispensing methadone for OUD treatment requires three separate authorizations: (1) an active DHCS § 11835 OTP license from the California Department of Health Care Services; (2) an active DEA Schedule II narcotic treatment program registration (DEA Form 363 registration) from the U.S. Drug Enforcement Administration; and (3) active SAMHSA/CSAT federal OTP certification under 42 CFR Part 8 from the Substance Abuse and Mental Health Services Administration. An OTP that holds two of the three but lacks one is operating unlawfully — all three are required for lawful methadone dispensing in a California OTP.
- Can a physician with an individual DEA buprenorphine waiver (DATA 2000) operate a facility-based OTP dispensing program for multiple patients?
- No. An individual DEA Schedule III practitioner registration with a buprenorphine prescribing waiver under the now-repealed DATA 2000 framework (consolidated under the SUPPORT Act) authorizes an individual physician to prescribe buprenorphine for OUD to individual patients in an office-based treatment setting. A facility-based OTP that dispenses buprenorphine as a program to multiple patients — rather than individual physicians prescribing to individual patients — requires DHCS § 11835 OTP licensure and a DEA OTP-specific narcotic treatment program registration separate from the individual physician's prescribing authority.
- How does AATOD Standards for OTPs serve as PURE KETCHUM advisory evidence in a § 11835 fee petition?
- AATOD Standards for Opioid Treatment Programs (2023 Edition) — published by AATOD (founded 1984, New York NY, 600+ OTP member programs) — establishes the national OTP provider organization compliance baseline: DHCS OTP license + DEA registration as prerequisite (Standard 1), individualized dosing protocols and physician involvement (Standard 4), and diversion prevention, take-home criteria, and urine drug screening (Standard 7). AATOD Standards are PURE KETCHUM advisory evidence — national OTP provider trade association standards, not independent fee-shifting statutes.
- How does NAADAC Code of Ethics serve as PURE KETCHUM advisory evidence?
- NAADAC Code of Ethics for Addiction Professionals (2021 Edition) — published by NAADAC (founded 1974, Alexandria VA, 100,000+ addiction professional members) — establishes the addiction counselor workforce ethics baseline for OTP practice: DHCS OTP license as prerequisite for counseling practice (Principle 1), 42 CFR Part 2 competency and patient confidentiality (Principle 4), and mandatory reporting and patient welfare obligations (Principle 7). NAADAC Code is PURE KETCHUM advisory evidence — DISTINCT from AATOD (AATOD = OTP provider organization standards; NAADAC = individual addiction professional ethics).
- What is the estimated annual billing gap for a solo attorney handling § 11835 unlicensed OTP matters?
- The estimated billing gap is 13.25 hours: Gap 1 (DHCS SUD directory + DEA registrant verification; AATOD Standards 1/4/7 review; NAADAC Principles 1/4/7 review; client intake; §11835 analysis; patient census; dispensing records; physician oversight documentation; diversion incident review — 5.25 hrs); Gap 2 (Ketchum memo; CCP §1021.5 public benefit analysis; OUD patient harm quantification; fee petition draft — 4.00 hrs); Gap 3 (Welch declaration; DHCS + DEA records; AATOD and NAADAC exhibits; patient records; dispensing logs; diversion records; community harm documentation; hearing prep — 4.00 hrs). At $300–$500/hr: $3,975–$6,625 per matter — billable time ClaimHour captures automatically without manual entry.